Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

14.12
+0.35002.54%
Post-market: 14.120.00000.00%19:30 EDT
Volume:1.11M
Turnover:15.33M
Market Cap:898.00M
PE:-6.03
High:14.17
Open:13.86
Low:13.31
Close:13.77
52wk High:28.00
52wk Low:8.16
Shares:63.60M
Float Shares:47.12M
Volume Ratio:1.48
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3433
EPS(LYR):-3.1931
ROE:-89.18%
ROA:-33.59%
PB:0.31
PE(LYR):-4.42

Loading ...

BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million

Reuters
·
May 08

Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 08

Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists

Simply Wall St.
·
May 02

A Look At Jade Biosciences (JBIO) Valuation After Its Recent Share Price Surge

Simply Wall St.
·
Apr 28

Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 27

Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright

TIPRANKS
·
Apr 27

Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $45 From $35

THOMSON REUTERS
·
Apr 27

Jade Biosciences grants CMO Conner stock options for 500,000 shares at $25.38

Reuters
·
Apr 23

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 23

Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), Elevance Health (ELV) and Regeneron (REGN)

TIPRANKS
·
Apr 23

Jade Biosciences appoints Edward Conner as chief medical officer

TIPRANKS
·
Apr 22

Press Release: Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer

Dow Jones
·
Apr 22

We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely

Simply Wall St.
·
Apr 21

Jade Biosciences announces annual shareholder meeting

Reuters
·
Apr 18

Jade Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
Apr 17

Jade Biosciences (JBIO) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Apr 06